目的 考察聚合物,包括亲水凝胶骨架材料及膨胀剂,对盐酸环丙沙星胃漂浮缓释片漂浮性能和释放行为的影响。方法 分别以羟丙甲纤维素(HPMC),羟丙纤维素(HPC)和羟乙基纤维素(HEC)为亲水凝胶骨架材料,以交联聚维酮(PVPP XL,PVPP XL-10)和交联羧甲基纤维素钠(CCS)为膨胀剂,制备盐酸环丙沙星胃漂浮缓释片,以起漂时间,漂浮持续时间和漂浮力为指标评价漂浮性能,以盐酸环丙沙星释放度为指标评价缓释性能。 结果 羟丙甲纤维素K250与交联聚维酮交联聚维酮XL合用可以获得起漂时间较短,漂浮持续时间较长且药物体外释放较理想的盐酸环丙沙星胃漂浮缓释片。结论 聚合物的种类和用量对胃漂浮片的漂浮性能和药物释放特性具有显著影响,羟丙甲纤维素K250和交联聚维酮XL是制备盐酸环丙沙星胃漂浮缓释片的较合适聚合物。
Abstract
OBJECTIVE To investigate the effect of polymers , including hydrophilic polymers and swelling aids, on floatability and dissolution of ciprofloxacin hydrochloride gastro-retentive tablets. METHODS Hydroxypropyl methyl cellulose (HPMC),hydroxyethylcellulose (HEC ) and hydroxypropylcellulose (HPC) were used as hydrophilic swelling excipients , and disintegrants crospovidone (PVPP XL and PVPP XL-10) or croscarmellose sodium (CCS) were used as swelling agents to facilitate the swelling /floating and drug release. Initial floating time and floating duration were tested to evaluate buoyance, and drug dissolution was tested to evaluate the controlled release. RESULTS Using HPMC K250 and PVPP XL as excipients for ciprofloxacin hydrochloride gastro-retentive tablets could obtain products with rapid onset of floating, long floating durion and desirable drug release. CONCLUSION Variety and amount of polymers have dramatic effects on buoyance and drug release of gastro-retentive tablets. HPMC K250 and PVPP XL are suitable excipients for ciprofloxacin hydrochloride gastro-retentive tablets.
关键词
盐酸环丙沙星 /
亲水骨架材料 /
膨胀剂 /
胃漂浮缓释片 /
起漂时间 /
释放度
{{custom_keyword}} /
Key words
ciprofloxacin hydrochloride /
hydrophilic polymer /
swelling agent /
gastro-retentive tablet /
initial floating time /
dissolution
{{custom_keyword}} /
中图分类号：
R944
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] SHI Z Q, JIANG X G. Research progress of floating drug delivery system[J]. Chin J Pharm(中国医药工业杂志), 2003,34(4):199-202.
[2] PYANG X,HU L D. Preparation and in vitro release of ciprofloxacin hydrochloride floating sustained-release tablets[J]. Chin J Pharm(中国医药工业杂志), 2007, 38(11):776.
[3] PIAO H Z,LIM W H,LI C F,et al. Effect of excipients on preparation of gastric-floating tablets and its floating abilities[J]. J Shenyang Pharm Univ (沈阳药科大学学报),2008,25(2):89-94.
[4] NEI Y, LI Y X,ZHU S S. Effect of excipients on the floating properties of gastric floating drug dosage form[J]. Cent South Pharm(中南药学), 2008,6(2):208-210.
[5] LI S F, LIN S S , DAGGYC B P,et al. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design[J]. Int J Pharm,2003,253(1-2):13-22.
[6] MAHESH C, PARAS J, SACHIN C,et al. Development of sustained release gastroretentive drug delivery system for ofloxacin in vitro and in vivo evaluation [J]. Int J Pharm,2005,304(1-2):178-184.
[7] RAMJI A K, CHANDRA S R G, PRABHAKAR R V. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin HCl tablets[J]. AAPS Pharm Scitech,2009,10(1):220-226.
[8] TANG Y,HE F Y,LIU Z, et al. Formulation study of huperzine A gastric-floating tablets by orthogonal experimentdesign [J]. Chin Tradit Pat Med(中成药),2010, 32(4):594-596.
[9] BEN X R,WANG Z G,YE G H,et al. Study on ranitidine bismuth citrate intra-gastric floating sustained-release tablets[J]. Acad J Guangdong Coll Pharm(广东药学院学报),2011, 27(1):10-13.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(767 KB)
